InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Ren Ken Keyong. Officer active across 1 company, notably CASI Pharmaceuticals, Inc.. Aggregated, 4 filings have been published. Breakdown: 4 buys · 0 sell. Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Ren Ken Keyong is a declarant linked to CASI Pharmaceuticals, Inc. (XNAS), where he is CEO and Director. The record shows 4 filings in total, all within the sampled set of 4 most recent filings dated 2016-01-21, with the transaction nature indicated as Acquisition and buy and sell amounts of EUR 0 in this sample.